Congress Time
April 24, 2015 (Registration and Exhibition Booth Setup)
April 25-28, 2015 (Conference Opening)
Language
The official language of the Congress is English.
VISA
Visas are required for some nationalities to travel to China for this conference. Please contact your travel agent or the Chinese Consulate/Embassy in your country for exact details on the visa application procedure as soon as possible. Visa processing times can vary.
It is recommended that participants apply for a tourist visa. The organizing committee of WCV-2015 cannot issue any official letters of invitation for business visa applications due to Chinese regulations.
Liability and Insurance
The Congress Secretariat and Organizers cannot accept liability for personal accidents or loss of or damage to private property of participants. Participants are advised to take out their own personal travel and health insurance for their trip.
Currency and Banking
In China, only RMB is used. However, exchange centers can be found at airports, most hotels and large shopping centers. The exchange rate is due to the official rate (Bank of China). When exchanging money, please keep your receipt by which you can change any remaining RMB back to foreign currency when leaving China. Visa, Master, American Express are honored in many department stores and hotels. ATM could help you for changing RMB from your credit card. Banks usually open at 9:00 in the morning and close at 17:00 in the afternoon all working days.
Electricity
Electricity is supplied at 220V, 50Hz AC throughout China. Major hotels usually provide 115V outlet for razor.
Organizing Committee of WCV-2015
BIT Congress Inc.
Add: East Wing, F11, Building 1,
Dalian Ascendas IT Park, 1 Hui Xian Yuan,
Dalian Hi-tech Industrial Zone,
LN 116025, China
Tel: 0086-411-84799609-844
Fax: 0086-411-84796897
Email: monica@vaccinecon.com
Hosting Organization
Information Research Center of International Talent, China State Administration of Foreign Experts Affairs, China
Operating Organization
China Council for the Promotion of International Trade, Nanjing Sub-Council
Foreign Experts Databank of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
BIT Congress Inc., China
Executive Chair
Dr. Xiaodan Mei, President, BIT Congress, Inc., China
Program Coordinators of BIT Congress Inc.
Ms. Monica Shao, Ms. Rebecca Chen
Scientific Advisory Board
Dr. Hsien-Jue Steve Chu, Vice President, Ceva Sante Animale, USA
Dr. William Cunningham, Professor, University of California, Los Angeles, USA
Dr. Jonathan L. Heeney, Professor; Head, Lab of Viral Zoonotics, University of Cambridge, UK
Dr. Ratna B. Ray, Professor, Saint Louis University, USA
Dr. Jorge Blanco, President, SIGMOVIR Biosystems, Inc, USA
Dr. Nicholas Jackson, Associate Vice President; Head of R&D for the Dengue Vaccine, Sanofi Pasteur, USA
Dr. John T. Patton, Chief, Rotavirus Molecular Biology Section, National Institute of Allergy and Infectious Diseases, USA
Dr. Ali Azizi,Scientist and Adjunct Professor, Analytical Research and Development, Sanofi Pasteur, Canada
Dr. C. Fordham von Reyn, Professor of Medicine, Dartmouth Medical School, USA
Dr. Steven J Czinn, Professor and Chair, University of Maryland School of Medicine, USA
Dr. Louis H. Miller, Head, Malaria Cell Biology Section, NIAID, NIH, USA
Dr. Edward Wu, Program Project Manager, PATH Malaria Vaccine Initiative (MVI), USA
Dr. Gareth W. Peters, Assistant Professor, Department of Statistical Science, University College London (UCL), UK
Dr. Howard A. Liddle, Professor, University of Miami Miller School of Medicine, USA
Dr. K Flanagan, Head of Infectious Diseases Services, LGH Senior Lecturer, Department of Immunology, Monash University, Australia
Dr. Tzyy Choou Wu, Professor, Johns Hopkins School of Medicine, USA
Dr. Mazhar Khan, Professor, University of Connecticut, USA
Dr. Nobuo Sakai, General Manager, DENKA SEIKEN CO.,LTD., Japan
Dr. Yasmin Thanavala, Professor, Department of Immunology, Roswell Park Cancer Institute, USA
Dr. Robert M. Grant, Professor, University of California, San Francisco; Gladstone Institute of Virology and Immunology; San Francisco AIDS Foundation, USA
Dr. Hong Qin, Assistant Professor, Department of Lymphoma/Myeloma , The University of Texas, USA
Dr. Peter Billingsley, Vice President International Projects and Strategy, Sanaria Inc., USA